Methods: Between 2008 and 2017, patients enrolled for custom-made fenestrated-branched endograft repair were prospectively collected. Anatomic, procedural, and postoperative data were retrospectively analyzed. Lead period was defined as the time between the endograft order to the manufacturer and implantation. Aneurysm diameter, target visceral vessel (TVV) severe stenosis (>75% of ostial lumen), and number of planned TVVs were evaluated at preoperative computed tomography angiography. Patency of TVVs was evaluated intraoperatively. Aneurysm rupture and TVV occlusion during the lead period were assessed.
VS02. Endovascular Docking Station Minimizes Gutter Endoleaks During Parallel Stent Graft Thoracic Endovascular Aortic Repair-Endovascular Aneurysm Repair
Manish Mehta. Albany Medical College, Latham, NY Background: This video presentation provides a case of managing a symptomatic thoracoabdominal aneurysm with attention to minimizing gutter leaks. This is a step-by-step approach to the endovascular procedure. Objective: Hemodialysis (HD) patients frequently experience perturbations in hand function after arteriovenous fistula (AVF) placement, and most attribute this to access-related hand dysfunction. Our previous work has demonstrated that changes in hemodynamics poorly correlate with biomechanical hand outcomes; however, neuromotor changes modulating the spectrum of hand function after AVF placement are unknown. The aim of this study was to examine changes in neurophysiologic, biomechanical, and patient-perceived hand outcomes after AVF surgery.
Methods: Fifty-one patients prospectively underwent nerve conduction studies (NCS) and biomechanical testing on the median and ulnar nerves preoperatively as well as 6 weeks and 6 months postoperatively. Mixedeffect logistic regression was used to characterize NCS parameters and to determine effects of hand dominance, AVF configuration (radial vs brachial), HD status, and diabetes mellitus. Associations between changes in NCS parameters, concurrent biomechanical tests (grip strength, monofilament sensory nerve testing, Purdue peg board dexterity assessment), and the patient's perception of hand function (Disabilities of the Arm, Shoulder, and Hand questionnaire) were determined.
Results: Diabetic patients experienced more significant decreases in amplitude and conduction velocity (CV) as well as reciprocal increases in F-latency (P < .05) at all time points for both motor and sensory domains of the median and ulnar nerves. Ulnar motor CV was lower for all time points in patients on HD at time of AVF placement (P < .05). Patients on HD preoperatively also had lower ulnar sensory CV preoperatively and 6 weeks postoperatively (P < .05) as well as significantly reduced preoperative amplitude in median motor nerves. The diabetic and HD effects are depicted in Fig 1. Decreased amplitude, CV, and increased F-latency of the median and ulnar motor nerves were linearly associated with worsening grip strength and peg board measurements, as shown in Fig 2. Whereas Disabilities of the Arm, Shoulder, and Hand score changes did not consistently correlate with significant linear changes in NCS, the trend of increased subjective dysfunction and decreased nerve function was frequently observed. These signatures were most robust in the median and ulnar motor distributions. Hand dominance and AVF configuration did not significantly influence change in neurophysiologic or biomechanical outcomes.
Conclusions: This is the first description of the temporal changes in neurologic, biomechanical, and patient-perceived hand outcomes after AVF placement. Diabetes and dialysis status at time of access placement have significant effects on hand outcomes. Predictable associations between nerve parameters and objective measures of hand function are identified and provide novel insight into underlying mechanisms causing hand dysfunction after hemoaccess surgery.
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Efficacy of Surgical Correction of Dialysis Access Steal Syndrome
Juhi Ramchandani, Karthik Bhat, Samuel Steerman, David Dexter, Animesh Rathore, Jean M. Panneton. Eastern Virginia Medical School, Virginia Beach, Va
Objective: Surgical options to treat vascular access-related steal syndrome include distal revascularization-interval ligation (DRIL), proximalization of arterial inflow (PAI), access banding, and access ligation. The efficacy of these individual modalities in symptom resolution has not been previously reported. The aim of this study was to compare efficacy of different surgical modalities for treatment of steal associated with arteriovenous fistulas (AVFs) and arteriovenous grafts (AVGs).
Methods: Retrospective analysis was performed on adults diagnosed with steal syndrome after hemodialysis access creation who underwent revision of their dialysis access by a singular vascular specialty group within one integrated health care system. Patients <18 years, those with lower extremity accesses, and those with HeRO grafts (Merit Medical, South Jordan, Utah) were excluded. Data were obtained from the electronic medical record system and analyzed using SPSS software (IBM Corp, Armonk, NY). Patients with preintervention duplex ultrasound-confirmed steal were identified and further evaluated by access type (AVG or AVF). The primary end point was clinical symptom resolution.
Results: There were 257 patients who underwent surgical interventions for steal syndrome. Of these, 143 patients had a preoperative duplex ultrasound examination suggestive of steal syndrome, with 98 associated with AVF (68.5%) and 45 associated with AVG (31.5%). Our population included predominantly women (65.7%) and African Americans (53.8%), with a mean age of 63.2 years (23-90 years). Symptom resolution for the two groups is reported in the Fig. In the AVF group, there was a statistically significant difference for complete symptom resolution between DRIL, PAI, banding, and access ligation at 64.6%, 80%, 26.3%, and 100%, respectively (c 2 test, P ¼ .001). For AVGs, there was no statistically significant difference in symptom resolution between different surgical modalities (c 2 test; P ¼ .555).
Conclusions:
In patients with AVF-associated steal, efficacy of DRIL and PAI in symptom resolution was superior to banding with statistical significance. Whereas access ligation had a higher percentage of symptom resolution in this subset, it should be reserved for cases of severe disease or when other viable options are absent. For AVG, clinical judgment and symptoms should be used in guiding surgical treatment preferences for symptom resolution.
Author Disclosures: K. Bhat: Nothing to disclose; D. Dexter: Nothing to disclose; J. M. Panneton: Nothing to disclose; J. Ramchandani: Nothing to disclose; A. Rathore: Nothing to disclose; S. Steerman: Nothing to disclose. Objective: Although tapered dialysis access grafts are often used in an effort to prevent ischemic steal, their efficacy is uncertain. Our goal was to use real-world data to assess the performance of these grafts with respect to steal and primary patency.
RS03.
Tapered Arteriovenous Grafts
Methods: The Vascular Quality Initiative database was queried for all patients undergoing tapered dialysis grafts in the upper arm. We limited analysis to grafts including and proximal to the antecubital fossa. Multivariable analysis was performed to analyze outcomes.
Results: We identified 3608 grafts, 1473 tapered and 2135 nontapered. The mean age was 64.8 years, and 43.4% were male. Tapered grafts were used more often in female patients (60.5% vs 54%), nonwhite patients (53.3% vs 47.7%), no previous access (28% vs 26.3%), antecubital brachial artery origin (50% vs 44.4%), and antecubital cephalic vein target (7.4% vs 3.7%; P < .05). There was no difference between tapered and nontapered grafts at 6 months for primary patency (83.6% vs 84.6%; P ¼ .625), wound complications (4.8% vs 5.5%; P ¼ .739), significant arm swelling (6.3% vs 5.3%; P ¼ .43), or steal (4.1% vs 4.3%; P ¼ .87). At 1-year follow-up, tapered grafts had similar rates of endovascular (36% vs 38%; P ¼ .53) and surgical (14.1% vs 17.7%; P ¼ .12) interventions. Multivariable analysis revealed that tapered grafts did not affect primary patency (hazard ratio [HR] 
